rs2241766
A SNP in the ADIPOQ gene on chromosome 3. Its most notable genotype is G;G: Slightly lower risk of breast cancer
- Gene
- ADIPOQ
- Location
- Chr 3186,853,103 (GRCh38)
- Highest magnitude
- 2.0Worth knowing
- Tested on
- 23andMe
- Minor allele frequency
- 14%
Genotypes
As shown in 23andMe and AncestryDNA files.
- G;GMost notableGoodSlightly lower risk of breast cancer
- G;TGoodSlightly lower risk of breast cancer
- T;TNot ratedmost common genotype
On SNPedia: (G;G), (G;T), (T;T). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.
Related
Conditions, medicines and genes
Other ADIPOQ SNPs
- rs266729G;G0.73x decreased risk for colorectal cancerWorth knowing
- rs1501299T;Tslightly lower risk of breast cancerWorth knowing
- rs17300539A;Ahigher adiponectin levelsMinor
- rs16861194A;Acommon in complete genomicsTypical
- rs16861205G;Gcommon in complete genomicsTypical
- rs17366568G;Gcommon in complete genomicsTypical
- rs17366653T;Tcommon in complete genomicsTypical
- rs17366743T;TNo summary available.Typical
Genosets
- Gs326Reduced risk (0.15x) of breast cancer compared to averageImportant
- Gs325Reduced risk (0.64x) of breast cancer compared to averageImportant
Genosets combine several genotypes. Twofold checks them in your report.
Notes
From SNPedia
Show notes, about 380 words
rs2241766, also known as c.45T>G, represents a synonymous variant in the ADIPOQ gene on chromosome 3. Some studies report that the less common rs1501299(G) allele, is associated with decreased cancer risk compared with the more common (T) allele. A study of 733 breast cancer cases for 10 SNPs concluded that the rs2241766(G;T) genotype, in combination with certain genotypes at rs1501299, was at reduced risk (odds ratio 0.61, CI: 0.46-0.80). After categorizing individuals by adiponectin signaling status, this study found that compared with low signalers (the most frequent), intermediate signalers had a 0.64x decrease in breast cancer risk (CI: 0.49–0.83), and high signalers had a 0.15x lower breast cancer risk (CI: 0.02–1.28, p(trend) = 0.001). Adiponectin signaling status was assigned as follows (as oriented in dbSNP): rs1501299(C,C) + rs2241766(T,T) = low signaler rs1501299(A,C) + rs2241766(T,T) = low signaler rs1501299(C,C) + rs2241766(G,T) = low signaler rs1501299(A,A) + rs2241766(T,T) = intermediate signaler rs1501299(A,C) + rs2241766(G,T) = intermediate signaler rs1501299(C,C) + rs2241766(G,G) = intermediate signaler rs1501299(A,C) + rs2241766(G,G) = high signaler rs1501299(A,A) + rs2241766(G,G) = high signaler rs1501299(A,A) + rs2241766(G,T) = high signaler Based on these criteria, adiponectin signaling status is now determined by genosets Gs325 and Gs326 for Promethease users. Note that adiponectin, a hormone produced by adipose tissue (body fat), is involved in lipid metabolism. In other words, you are a low adiponectin signaler, and thus have basically average breast cancer risk, if you have one of these combinations of alleles: *rs1501299 CC and also rs2241766 either GT or TT *rs1501299 AC and also rs2241766 TT You are an intermediate adiponectin signaler (Gs325), and thus possibly at 0.64x reduced risk of breast cancer compared to low signallers, if you have one of these combinations of alleles: * rs1501299 CC and also rs2241766 GG * rs1501299 AC and also rs2241766 GT * rs1501299 AA and also rs2241766 TT You are a high adiponectin signaler (Gs326), and thus have the lowest (perhaps 0.15x) risk if you have one of these combinations of alleles: * rs1501299 AC and also rs2241766 GG * rs1501299 AA and also rs2241766 either GG or GT
Source and license
Adapted from rs2241766 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.
SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.